Lots of optimistic speculation here, which is great.
Some obvious downrampers too, as expected.
Just a thought - when speculating earnings or partnership/takeover/buyout offers....
It seems I hear from IMU that they will be offering products at much cheaper prices than current approaches/drugs such as keytruda, etc.
How much cheaper? I've no idea. But if it's, say, 40% cheaper, then revenue would be 40% less as well.
This may be counterbalanced by an increase in usage/application of successful IMU products.
My point is, speculation of sales figures/SP/partnerships/buyouts should factor in IMU's suggestions of much cheaper products.
Open to rebuttal. GLTAH.
Why IMU is a multi multi bagger, page-3593
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.5¢ |
Change
-0.001(1.32%) |
Mkt cap ! $548.9M | |||
| Open | High | Low | Value | Volume |
| 7.7¢ | 7.8¢ | 7.5¢ | $1.261M | 16.55M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 22 | 2015361 | 7.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.6¢ | 590270 | 2 |
View Market Depth
| Last trade - 16.10pm 08/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.5¢ |
Change
-0.001 ( 1.32 %) |
||||
| Open | High | Low | Volume | ||
| 7.6¢ | 7.8¢ | 7.5¢ | 8715272 | ||
| Last updated 15.59pm 08/05/2024 ? | |||||
| IMU (ASX) Chart |